---
figid: PMC2984606__aging-02-567-g006
figlink: /pmc/articles/PMC2984606/figure/F6/
number: Figure 6
caption: In adult worms the FGFR EGL-15(5A) targeted for activation by the Klotho
  KL1 isoform can allow EGL-17 ligand binding. Under physiological conditions, the
  Klotho/EGL-15/EGL-17 complex constitutively represses the DAF-2 (Insulin/Igf-like)
  receptors by a still unknown pathway. Such complexes may induce DAF-16 (FOXO) de-repression
  and subsequent overexpression of longevity factors, such as antioxidant enzymes.
  When worms have to cope with a potent stress, the Klotho/EGL-15/EGL-17 complex may
  directly activate DAF-16 by a DAF-2-independent pathway (dashed line). Such activation
  mechanism remains to be elucidated.
pmcid: PMC2984606
papertitle: Klotho interferes with a novel FGF-signalling pathway and insulin/Igf-like
  signalling to improve longevity and stress resistance in Caenorhabditis elegans.
reftext: Marie-Thérèse Château, et al. Aging (Albany NY). 2010 Sep;2(9):567-581.
pmc_ranked_result_index: '64127'
pathway_score: 0.8718035
filename: aging-02-567-g006.jpg
figtitle: In adult worms the FGFR EGL-15(5A) targeted for activation by the Klotho
  KL1 isoform can allow EGL-17 ligand binding
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2984606__aging-02-567-g006.html
  '@type': Dataset
  description: In adult worms the FGFR EGL-15(5A) targeted for activation by the Klotho
    KL1 isoform can allow EGL-17 ligand binding. Under physiological conditions, the
    Klotho/EGL-15/EGL-17 complex constitutively represses the DAF-2 (Insulin/Igf-like)
    receptors by a still unknown pathway. Such complexes may induce DAF-16 (FOXO)
    de-repression and subsequent overexpression of longevity factors, such as antioxidant
    enzymes. When worms have to cope with a potent stress, the Klotho/EGL-15/EGL-17
    complex may directly activate DAF-16 by a DAF-2-independent pathway (dashed line).
    Such activation mechanism remains to be elucidated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXO4
  - FOXO1
  - FGFRL1
  - FGF8
  - KITLG
  - FGFR1
  - FGFR2
  - FOXO3
  - FOXO6
  - FGFR3
  - FGFR4
genes:
- word: (FOXO)
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: (FOXO)
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: (FGFR)
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: (FGF8
  symbol: FGF8
  source: hgnc_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: KL1
  symbol: KL-1
  source: hgnc_alias_symbol
  hgnc_symbol: KITLG
  entrez: '4254'
- word: (FGFR)
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: (FGFR)
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: (FOXO)
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: (FOXO)
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: (FGFR)
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: (FGFR)
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
chemicals: []
diseases: []
---
